nippon shinyaku co ltd (4516) Snapshot

Nippon Shinyaku Co. Ltd. announced the launch of “Regtect Tablets 333mg” (Generic name: Acamprosate calcium) for support maintenance of abstinence in patients with alcohol dependence. Alcohol dependence is a clinical condition in which a patient is unable to control drinking behaviors due to addictive alcohol intake. Regardless of gender, age or occupation, anyone who drinks alcohol has a possibility of suffering alcohol dependence. Patients with alcohol dependence have the strong and irresistible craving for alcohol, which cause pathological alcohol intake such as addictive drinking. Regtect Tablets 333mg” affects central nerve system and inhibits the hyperactivity of glutamatergic nerve system induced by alcohol dependence, and such novel mode of action is thought to contribute to reduce craving for alcohol. According to the results of clinical studies conducted in Japan, Regtect showed significant improvement on success rate of abstinence (complete abstinence rate at the end of 24-week administration period) than placebo, when used as combinational drug with psychosocial treatment including psychotherapy such as counseling or joining self-help group.

Nippon Shinyaku Co. Ltd. reported consolidated earnings results for the year ended March 31, 2013. For the year, the group (consolidated) reported net sales of ¥69,941 million, operating income of ¥6,901 million, ordinary income of ¥7,209 million and net income of ¥4,647 million or ¥68.87 per basic share compared to net sales of ¥67,304 million, operating income of ¥6,012 million, ordinary income of ¥6,193 million and net income of ¥3,715 million or ¥55.04 per basic share reported in the same period last year. Cash flows from operating activities were ¥3,767 million against ¥3,658 million reported last year. Income before income taxes and minority interests was ¥7,286 million against ¥6,193 million reported last year. Net cash provided by operating activities was ¥3,767 million against ¥3,658 million reported last year. Purchases of tangible fixed assets was ¥1,020 million against ¥988 million reported last year. Purchases of intangible assets was ¥359 million against ¥128 million reported last year. For the year, the company declared a year end dividend of ¥11.00 per share compared to ¥10.00 per share declared last year. Scheduled start of payment of dividend is June 28, 2013. For the fiscal 2013, the forecasts an interim dividend of ¥11.00 per share at the end of the second quarter and an year end dividend of ¥12 per share, which bring total dividend to ¥23.00 per share compared to interim dividend of ¥10.00 per share and year end dividend of ¥11.00 per share declared last year. For the year ending March 31, 2014, the company expects to report net sales of ¥74,300 million, operating income of ¥7,600 million, ordinary income of ¥7,900 million and net income of ¥5,400 million or ¥80.03 per basic share. For the half year of fiscal ending March 31, 2014, the company expects to report net sales of ¥34,600 million, operating income of ¥3,200 million, ordinary income of ¥3,400 million and net income of ¥2,300 million or ¥34.09 per basic share.

Nippon Shinyaku Co. Ltd. announced that they will report fiscal year 2013 results on May 13, 2013